D A Winegar Selected Research

GW 9578

9/2001	The characterization of PPAR alpha ligand drug action in an in vivo model by comprehensive differential gene expression profiling.
6/2000	Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D A Winegar Research Topics

Disease

3	Dyslipidemias (Dyslipidemia) 10/2001 - 06/2000
2	Body Weight (Weight, Body) 10/2001 - 06/2000
2	Hyperlipidemias (Hyperlipidemia) 10/2001 - 12/2000
2	Insulin Resistance 10/2001 - 06/2000
1	Type 2 Diabetes Mellitus (MODY) 10/2001
1	Obesity 10/2001
1	Hypertriglyceridemia 10/2001
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 09/2001
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2001
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2001
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2000
1	Hyperinsulinism (Hyperinsulinemia) 06/2000
1	Hyperglycemia 06/2000
1	Infections 02/2000

Drug/Important Bio-Agent (IBA)

2	Fibric Acids (Fibrates)IBA 10/2001 - 06/2000
2	LipidsIBA 10/2001 - 05/2001
2	Fenofibrate (CiL)FDA LinkGeneric 10/2001 - 06/2000
2	Triglycerides (Triacylglycerol)IBA 10/2001 - 12/2000
2	GW 9578IBA 09/2001 - 06/2000
2	PPAR alphaIBA 05/2001 - 06/2000
2	PPAR deltaIBA 05/2001 - 04/2001
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 10/2001
1	HDL CholesterolIBA 10/2001
1	Glucose (Dextrose)FDA LinkGeneric 10/2001
1	Insulin (Novolin)FDA Link 10/2001
1	PPAR gammaIBA 05/2001
1	GW 7647IBA 05/2001
1	CholesterolIBA 04/2001
1	RetinoidsIBA 12/2000
1	HIV Protease InhibitorsIBA 12/2000
1	ciprofibrateIBA 06/2000
1	ThiazolidinedionesIBA 06/2000
1	AntibodiesIBA 02/2000

Therapy/Procedure

1	Therapeutics 12/2000